Brand : Lunit
Perfecting Intelligence, Transforming Medicine
Advancing medical intelligence to the next level
Lunit is a medical AI software company devoted to conquering cancer and advancing medical intelligence to the next level. Lunit develops and provides novel AI-powered solutions for cancer diagnostics and therapeutics that can save time and save lives.
Lunit INSIGHT CXR3
Developed using Lunit’s cutting-edge deep learning technology,11-14 which has been validated through publications in numerous major publications such as Radiology,15-16 Scientific Reports,17 Clinical Infectious Diseases18 and more, Lunit INSIGHT CXR 3 accurately detects 10 of the most common findings in a chest x-ray, which includes atelectasis, calcification, cardiomegaly, consolidation, fibrosis, mediastinal widening, nodule, pleural effusion, pneumoperitoneum, and pneumothorax. The AI solution generates (1) location information of detected lesions in the form of heatmaps, (2) abnormality scores reflecting the probability that the detected lesion is abnormal, and (3) an AI “case report” that summarizes the analysis result by each finding. The solution is indicated to be directly involved in the primary interpretation process of radiologists or clinicians.
Lunit INSIGHT MMG For Breast Cancer Detection
Developed using Lunit’s cutting-edge deep learning technology,6 Lunit INSIGHT MMG accurately detects lesions suspicious of breast cancer in the form of diagnostic support tool. The AI solution generates (1) location information of detected lesions in the form of heatmaps and (2) abnormality scores reflecting the probability that the detected lesion is malignant. The solution is indicated to be directly involved in the primary interpretation process of radiologists.
Developed using Lunit’s cutting-edge deep learning technology4, Lunit SCOPE accurately detects cancer stroma, cancer epithelium and lymphocytes in H&E whole slide images. The AI solution generates (1) intratumoral TIL density information (2) stromal TIL density information, and (3) cancer stroma-epithelium ratio. The solution can also classify tissues in terms of immune phenotype.
- Raised $26M (Series C, Tranche A)
- Europe CE certified,
- Awarded by World Economic Forum as one of 100 “Technology Pioneer 2020
- Digital Health 150, by CB Insights
- Ministry of Korea Food and Drug Safety clearance,
- Europe CE marked,
- 1st place in
- Top 100 AI startup, by CB Insights
- Top 5 “Social Impact” AI startup, by NVIDIA
- Ranked 1st place in
- 5th place in
- Launched its first product,
2013 Lunit Inc. founded
Introducing: Lunit INSIGHT “The First-ever, Real-time Imaging AI Analytics on the Web”
Lunit presentation at ECR 2020